References
- Ahmadi SA, Moinfar M, Gohari Moghaddam K, Bahadori M (2010). Practical application of angiogenesis and vasculogenic mimicry in prostatic adenocarcinoma. Arch Iran Med, 13, 498-503.
- Amsterdam A, Raanan C, Schreiber L, Polin N, Givol D (2013). LGR5 and Nanog identify stem cell signature of pancreas beta cells which initiate pancreatic cancer. Biochem Biophys Res Commun, 433, 157-62. https://doi.org/10.1016/j.bbrc.2013.02.038
- Barker N, Huch M, Kujala P, et al (2010). Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell, 6, 25-36. https://doi.org/10.1016/j.stem.2009.11.013
- Bu Z, Zheng Z, Zhang L, et al (2013). LGR5 is a promising biomarker for patients with stage I and II gastric cancer. Chin J Cancer Res, 25, 79-89.
- Curley MD, Therrien VA, Cummings CL, et al (2009). CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells. 27, 2875-83.
- Economopoulou P, Kaklamani VG, Siziopikou K (2012). The role of cancer stem cells in breast cancer initiation and progression, potential cancer stem cell-directed therapies. The oncologist. 17, 1394-401. https://doi.org/10.1634/theoncologist.2012-0163
- EI Hallani S, Boisselier B, Peglion F, et al (2010). A new alternative mechanism in glioblastoma vascularization, tubular vasculogenic mimicry. Brain, 133, 973-982. https://doi.org/10.1093/brain/awq044
-
Femia AP, Dolara P, Salvadori M, Caderni G (2013). Expression of LGR-5, MSI-1 and DCAMKL-1, putative stem cell markers, in the early phases of 1,2-dimethylhydrazineinduced rat colon carcinogenesis, correlation with nuclear
${\beta}$ -catenin. BMC Cancer, 13, 48. https://doi.org/10.1186/1471-2407-13-48 - Flesken-Nikitin A, Hwang CI, Cheng CY, et al (2013). Ovarian surface epithelium at the junction area contains a cancerprone stem cell niche. Nature, 495, 241-5. https://doi.org/10.1038/nature11979
- Fu D, He X, Yang S, et al (2011). Zoledronic acid inhibits vasculogenic mimicry in murine osteosarcoma cell line in vitro. BMC Musculoskelet Disord, 12, 146. https://doi.org/10.1186/1471-2474-12-146
- Hashimoto K, Aoyagi K, Isobe T, Kouhuji K, Shirouzu K (2014). Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer. Gastric Cancer, 17, 97-106. https://doi.org/10.1007/s10120-013-0255-9
- Hendrix MJ, Seftor EA, Hess AR, Seftor RE (2003). Vasculogenic mimicry and tumour-cell plasticity, lessons from melanoma. Nat Rev Cancer, 3, 411-21. https://doi.org/10.1038/nrc1092
- Hilbe W, Dirnhofer S, Oberwasserlechner F, et al (2004). CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol, 57, 965-9. https://doi.org/10.1136/jcp.2004.016444
- Huang J, Chen K, Gong W, Dunlop NM, Wang JM (2008). G-protein coupled chemoattractant receptors and cancer. Front Biosci, 13, 3352-63.
- Immervoll H, Hoem D, Sakariassen PO, Steffensen OJ, Molven A (2008). Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer, 8, 48. https://doi.org/10.1186/1471-2407-8-48
- Jiang J, Liu W, Guo X, et al (2011). IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer. Oncogene, 30, 4498-508. https://doi.org/10.1038/onc.2011.154
- Li M, Gu Y, Zhang Z, et al (2010). Vasculogenic mimicry, a new prognostic sign of gastric adenocarcinoma. Pathol Oncol Res, 16, 259-66. https://doi.org/10.1007/s12253-009-9220-7
- Lin KK, Andersen B (2008). Have hair follicle stem cells shed their tranquil image? Cell Stem Cell, 3, 581-2. https://doi.org/10.1016/j.stem.2008.11.005
- Liu TJ, Sun BC, Zhao XL, et al (2013). CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer. Oncogene, 32, 544-53. https://doi.org/10.1038/onc.2012.85
- Liu Z, Dai W, Jiang L, Cheng Y (2014). Over-expression of LGR5 correlates with poor survival of colon cancer in mice as well as in patients. Neoplasma, 61, 177-85. https://doi.org/10.4149/neo_2014_016
- Long H, Xiang T, Qi W, et al (2015). CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition. Oncotarget. [Epub ahead of print].
- Long H, Xie R, Xiang T, et al (2012). Autocrine CCL5 signaling promotes invasion and migration of CD133+ ovarian cancer stem-like cells via NF-kappaB-mediated MMP-9 upregulation. Stem Cells, 30, 2309- 19. https://doi.org/10.1002/stem.1194
- Malanchi I, Santamaria-Martinez A, Susanto E, et al (2012). Interactions between cancer stem cells and their niche govern metastatic colonization. Nature. 481, 85-9. https://doi.org/10.1038/nature10694
- Maniotis AJ, Folberg R, Hess A, et al (1999). Vascular channel formation by human melanoma cells in vivo and in vitro, vasculogenic mimicry. Am J Pathol, 155, 739-752. https://doi.org/10.1016/S0002-9440(10)65173-5
- McClanahan T, Koseoglu S, Smith K, et al (2006). Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors. Cancer Biol Ther, 5, 419-26. https://doi.org/10.4161/cbt.5.4.2521
- Miraglia S, Godfrey W, Yin AH, et al (1997). A novel fivetransmembrane hematopoietic stem cell antigen, isolation, characterization, and molecular cloning. Blood, 90, 5013-21.
- O'Brien CA, Pollett A, Gallinger S, Dick JE (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445, 106-110. https://doi.org/10.1038/nature05372
- Peichev M, Naiyer AJ, Pereira D, et al (2000). Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood, 95, 952-8.
- Rosen JM, Jordan CT (2009). The increasing complexity of the cancer stem cell paradigm. Science, 324, 1670-3. https://doi.org/10.1126/science.1171837
- Sato T, Clevers H (2013). Growing self-organizing miniguts from a single intestinal stem cell, mechanism and applications. Science, 340, 1190-4. https://doi.org/10.1126/science.1234852
- Schneider M, Huber J, Hadaschik B, et al (2012). Characterization of colon cancer cells, a functional approach characterizing CD133 as a potential stem cell marker. BMC Cancer, 12, 96. https://doi.org/10.1186/1471-2407-12-96
- Scully S, Francescone R, Faibish M, et al (2012). Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas. J Neurosci, 32, 12950-60. https://doi.org/10.1523/JNEUROSCI.2017-12.2012
- Shirakawa K, Wakasugi H, Heike Y, et al (2002). Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer, 99, 821-8. https://doi.org/10.1002/ijc.10423
- Singh SK, Hawkins C, Clarke ID, et al (2004). Identification of human brain tumour initiating cells. Nature, 432, 396-401. https://doi.org/10.1038/nature03128
- Steg AD, Bevis KS, Katre AA, et al (2012). Stem cell pathways contribute to clinical chemoresistance in ovarian cancer. Clin Cancer Res, 18, 869-81. https://doi.org/10.1158/1078-0432.CCR-11-2188
- Sun B, Qie S, Zhang S, et al (2008). Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors. Hum Pathol, 39, 445-51.
- Sun B, Zhang S, Zhao X, Zhang W, Hao X (2004). Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Int J Oncol, 25, 1609-14.
- Sun D, Sun B, Liu T, et al (2013). Slug promoted vasculogenic mimicry in hepatocellular carcinoma. J Cell Mol Med, 17, 1038-47. https://doi.org/10.1111/jcmm.12087
- Sun W, Fan YZ, Zhang WZ, Ge CY (2011). A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro. J Exp Clin Cancer Res, 30, 46. https://doi.org/10.1186/1756-9966-30-46
- Tang HS, Feng YJ, Yao LQ (2009). Angiogenesis, vasculogenesis, and vasculogenic mimicry in ovarian cancer. Int J Gynecol Cancer, 19, 605-10. https://doi.org/10.1111/IGC.0b013e3181a389e6
- Torre LA, Bray F, Siegel RL, et al (2015). Global cancer statistics, 2012. CA Cancer J Clin, 65, 87-108. https://doi.org/10.3322/caac.21262
- Valyi-Nagy K, Kormos B, Ali M, Shukla D, Valyi-Nagy T (2012). Stem cell marker CD271 is expressed by vasculogenic mimicry-forming uveal melanoma cells in three-dimensional cultures. Mol Vis, 18, 588-92.
- Vermeulen L, Todaro M, de Sousa Mello F, et al (2008). Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci USA, 105, 13427-32. https://doi.org/10.1073/pnas.0805706105
- Wu S, Yu L, Wang D, et al (2012). Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry. BMC Cancer, 12, 535. https://doi.org/10.1186/1471-2407-12-535
- Wu XS, Xi HQ, Chen L (2012). Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival. World J Surg Oncol, 10, 244. https://doi.org/10.1186/1477-7819-10-244
- Yan X, Ma L, Yi D, et al (2011). A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations. Proc Natl Acad Sci U S A, 108, 1591-6. https://doi.org/10.1073/pnas.1018696108
- Yang L, Levi E, Zhu S, Du J, Majumdar AP (2013). Cancer stem cells biomarkers in gastric carcinogenesis. J Gastrointest Cancer, 44, 428-35. https://doi.org/10.1007/s12029-013-9534-2
- Yao X, Ping Y, Liu Y, et al (2013). Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells. PLoS One, 8, 57188. https://doi.org/10.1371/journal.pone.0057188
- Yin AH, Miraglia S, Zanjani ED, et al (1997). AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood, 90, 5002-12.
- Zarkoob H, Taube JH, Singh SK, Mani SA, Kohandel M (2013). Investigating the link between molecular subtypes of glioblastoma epithelial-mesenchymal transition and CD133 cell surface protein. PLoS One, 8, 64169. https://doi.org/10.1371/journal.pone.0064169
- Zhang D, Sun B, Zhao X, et al (2014). Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer. Mol Cancer, 13, 207. https://doi.org/10.1186/1476-4598-13-207
- Zhang Y, Sun B, Zhao X, et al (2013). Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma. J Surg Oncol, 49, 3914-23.
- Zhao P, Li Y, Lu Y (2010). Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma. BMC Cancer, 10, 218. https://doi.org/10.1186/1471-2407-10-218
- Zhu L, Gibson P, Currle DS, et al (2009). Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature, 457, 603-7. https://doi.org/10.1038/nature07589
Cited by
- Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis vol.19, pp.2, 2016, https://doi.org/10.1007/s10456-016-9500-2
- -positive cancer cells in intramucosal gastric signet-ring cell carcinoma vol.66, pp.9, 2016, https://doi.org/10.1111/pin.12451
- Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer vol.95, pp.42, 2016, https://doi.org/10.1097/MD.0000000000005163
- Correlation Between Tumor Vasculogenic Mimicry and Poor Prognosis of Human Digestive Cancer Patients: A Systematic Review and Meta-Analysis pp.1532-2807, 2019, https://doi.org/10.1007/s12253-018-0496-3